Abstract
Although it is difficult to limit the outstanding multiple sclerosis research in 2019 to a selection of publications, the most important advances were made in the identification of sensitive biomarkers for predicting and monitoring disability progression. The use of MRI to estimate long-term disease progression in multiple sclerosis has previously yielded mixed results; however, new research using novel imaging strategies could bring new clarity.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
